ASHLEY TONSETIC: Open Payments
NPI 1912669946 · GRINDSTONE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,441 in 210 payments from 14 companies in 2025. Trend: 2023 $2,203 · 2024 $2,253 · 2025 $3,441
Food & beverage: $3,441
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 82 | $1,132 |
| Vanda Pharmaceuticals Inc. | 16 | $350 |
| Alkermes, Inc. | 14 | $305 |
| Teva Pharmaceuticals USA, Inc. | 13 | $288 |
| Otsuka America Pharmaceutical, Inc. | 15 | $277 |
| Neurocrine BioSciences, Inc. | 17 | $256 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $252 |
| Janssen Pharmaceuticals, Inc | 10 | $173 |
| Lundbeck LLC | 12 | $162 |
| Supernus Pharmaceuticals, Inc. | 9 | $147 |
Products named: VRAYLAR, REXULTI, ARISTADA, INGREZZA, CAPLYTA, FANAPT, AUSTEDO XR, Qelbree.
Industry payments across PA — which companies pay providers there.
